Pfizer Will be Protected By Biotech’s Fundamentals

Pfizer (NYSE:PFE) in my opinion will be protected by the strong fundamentals in this sector. As we can see from the chart below, the stock has traded in a range over the past 24 months. The stock pays out a current 3.42% yield and is an excellent trading stock due to its high liquidity. Implied volatility is low at present so one should probably wait to sell option premium in here.

I still maintain having a bullish stance trading this stock. Its newcomers such as Xeljanz and Ibrance are growing like gangbusters since being launched and with Xtandi expected to be on the books before years end, I can’t see this stock going much lower. When volatility spikes in Pfizer, one could retain a bullish bias by selling a larger amount of put options in the underlying compared to calls.

5g

About Individual Trader

Helping You Navigate The Markets For Profit
This entry was posted in Trading and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s